Shanghai MicuRx Pharmaceutical Co., Ltd. (SHA:688373)
China flag China · Delayed Price · Currency is CNY
6.15
-0.12 (-1.91%)
At close: Mar 19, 2026

SHA:688373 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,9573,9603,2374,2795,805-
Market Cap Growth
-3.52%22.34%-24.35%-26.30%--
Enterprise Value
3,8383,8412,8003,4434,701-
Last Close Price
6.036.044.946.538.86-
PS Ratio
27.9127.9324.8547.13120.42-
PB Ratio
15.3615.387.375.134.78-
P/TBV Ratio
15.4315.447.405.144.79-
EV/Sales Ratio
27.0727.0921.5037.9397.53-
Debt / Equity Ratio
1.421.420.690.270.190.37
Net Debt / Equity Ratio
-0.46-0.46-0.66-0.88-0.86-0.71
Net Debt / EBITDA Ratio
0.490.490.671.674.061.16
Net Debt / FCF Ratio
--0.652.174.121.53
Asset Turnover
--0.130.070.050.01
Inventory Turnover
--0.500.560.540.09
Quick Ratio
--3.057.1411.135.03
Current Ratio
--3.537.7211.915.41
Return on Equity (ROE)
-69.38%-69.38%-69.24%-41.12%-26.66%-42.75%
Return on Assets (ROA)
---27.18%-20.63%-15.00%-25.55%
Return on Capital Employed (ROCE)
---68.90%-42.60%-18.60%-48.60%
Earnings Yield
-6.11%-6.10%-13.62%-9.84%-3.79%-
FCF Yield
---13.84%-7.87%-4.34%-
Buyback Yield / Dilution
0.40%0.40%--13.09%-10.17%-106.16%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.